How To Invest In IPO Stocks (Part 1) - What To Read Inside The IPO Prospectus
Alkem Laboratories has received capital markets regulator Securities and Exchange Board of India’s (Sebi) approval to raise an estimated Rs 1,500-3,500-crore through an initial public offering (IPO). Alkem Laboratories filed the Draft Red Herring Prospectus (DRHP) with Sebi on August 6 for a public issue of its equity shares.
The (Sebi) has cleared the proposed initial share sale and gave its final observations on the IPO on October 19.
As per the draft papers, the company will come out with a public offer of up to 12,853,442 equity shares.
According to sources, the company is expected to mobilise Rs 1,500-3,500 crore through its maiden public offering.
The firm, which has a significant presence in the country, plans to expand its footprint internationally.
Mumbai-headquartered Alkem, which was founded in 1973, began operations as a healthcare marketing company.
It has proposed to list its shares on the NSE and BSE.
The issue is being managed by Nomura Financial Advisory and Securities (India), Axis Capital, J P Morgan India and Edelweiss Financial Services.
Add a comment
Click here to Login or to Register for free.
You will be taken back to your selected item after Login/Registration.